Tevfik Berk Bildaci

Abstract Endometrial atypical hyperplasia is recognized as a precursor to endometrial cancer, which ranks as the fourth most common cancer in women and is the leading type of gynecological malignancy in high-income countries. The development and progression of endometrial cancer are strongly linked to increased body fat and insulin resistance. Peptides involved in glucose metabolism, such as leptin, chemerin, and galanin, may contribute to carcinogenesis through shared pathways.